1. Home
  2. METC vs ALVO Comparison

METC vs ALVO Comparison

Compare METC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$15.27

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.59

Market Cap

998.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METC
ALVO
Founded
2015
2013
Country
United States
Luxembourg
Employees
900
1460
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
998.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
METC
ALVO
Price
$15.27
$3.59
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
$34.00
$8.00
AVG Volume (30 Days)
1.2M
322.9K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.61
$13.28
Revenue Next Year
$11.96
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$8.51
$3.03
52 Week High
$57.80
$11.85

Technical Indicators

Market Signals
Indicator
METC
ALVO
Relative Strength Index (RSI) 54.46 52.80
Support Level $15.08 $3.03
Resistance Level $15.98 $3.93
Average True Range (ATR) 0.86 0.19
MACD 0.11 0.01
Stochastic Oscillator 75.58 74.30

Price Performance

Historical Comparison
METC
ALVO

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: